Biomaterials · 2024 · 16 citations · 22 references
MedicineCancer BiologyOncologyImmunotherapyMolecular OncologyTumor ImmunologyCancer ImmunotherapyCancer NanomedicineMalignant NeoplasmsNanomedicineNeoantigen-based ImmunotherapyPancreatic CancerCancer Immunotherapy NanoparticlesCancer NanotherapyDna Damage InductionDna Damage Response InhibitorsDna Damage Response TargetingDna Damage SensorsNeoantigen ImmunotherapyOxidative Dna Damage
22
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal et al. · Science · 2016 · 3.1K citations · Full text
Life Sciences, Immunology, Oncology +17
Implementing TMB measurement in clinical practice: considerations on assay requirements
Reinhard Büttner, John Longshore, Fernando López‐Ríos et al. · ESMO Open · 2019 · 355 citations · Full text
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
Shixiang Wang, Zaoke He, Xuan Wang et al. · eLife · 2019 · 334 citations · Full text
Life Sciences, Immunology, Oncology +17
Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy
Wei Jiang, Wang Dong, Min Li et al. · ACS Nano · 2022 · 177 citations
Life Sciences, Immunology, Oncology +17